Atika Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.81M | Sell |
46,121
-27,579
| -37% | -$2.88M | 0.48% | 43 |
|
|
2025
Q1 | $8.6M | Buy |
73,700
+51,700
| +235% | +$6.03M | 1.21% | 25 |
|
|
2024
Q4 | $1.86M | Sell |
22,000
-35,000
| -61% | -$2.96M | 0.2% | 71 |
|
|
2024
Q3 | $5.12M | Buy |
57,000
+8,000
| +16% | +$719K | 0.53% | 55 |
|
|
2024
Q2 | $3.94M | Sell |
49,000
-19,000
| -28% | -$1.53M | 0.39% | 62 |
|
|
2024
Q1 | $5.43M | Buy |
68,000
+1,300
| +2% | +$104K | 0.53% | 58 |
|
|
2023
Q4 | $5.31M | Sell |
66,700
-4,300
| -6% | -$342K | 0.71% | 52 |
|
|
2023
Q3 | $4.96M | Sell |
71,000
-41,000
| -37% | -$2.87M | 0.65% | 51 |
|
|
2023
Q2 | $8.05M | Sell |
112,000
-43,000
| -28% | -$3.09M | 0.81% | 42 |
|
|
2023
Q1 | $9.56M | Sell |
155,000
-71,535
| -32% | -$4.41M | 1.41% | 22 |
|
|
2022
Q4 | $17.5M | Sell |
226,535
-37,795
| -14% | -$2.92M | 2.51% | 11 |
|
|
2022
Q3 | $11.8M | Buy |
264,330
+114,330
| +76% | +$5.1M | 1% | 35 |
|
|
2022
Q2 | $5.75M | Buy |
+150,000
| New | +$5.75M | 0.65% | 41 |
|